MTNB   $0.64  8.47% Market Closed After Close 0.64 0.0

Matinas Biopharma Holdings, Inc.
Total Cash 14.31M
totalCashPerShare 2.853
EBITDA -23.38M
Total Debt 3.24M
quickRatio 5.984
currentRatio 6.39
Total Revenue 0.00
debtToEquity 16.966
Revenue/Share 0.0
ROA -0.50870997
ROE -0.97586995
grossProfits
freeCashflow -9.13M
operatingCashflow -17.87M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue -8.31M
forwardPE -0.17666666
floatShares 4.89M
sharesOutstanding 5.02M
sharesShort 80.43K
sharesShortPriorMonth 78.66K
dateShortInterest
sharesPercentSharesOut 0.02%
heldPercentInsiders 0.03%
heldPercentInstitutions 0.28%
Short Ratio help_outline 2.24%
shortPercentOfFloat 0.02%
impliedSharesOutstanding
bookValue 3.808
Price To Book help_outline 0.14
earningsQuarterlyGrowth
netIncomeToCommon -22.91M
trailingEps -5.50%
forwardEps -3.00%
enterpriseToEbitda 0.36
lastDividendValue
lastDividendDate
currentQuarterEstimate -1.05 3Q 2024
institutionsCount 35
lastUpdated Nov. 7, 2024, 12:41 a.m.